文献速递骨质疏松与代谢性骨病

骨少肌症是否协同增加跌倒与骨折风险?系统综述与荟萃分析

Does osteosarcopenia synergistically increase risk for incident falls and fractures? A systematic review and meta-analysis.
PubMed 文献 · Osteoporos Int · 2026-03-23

该系统综述与荟萃分析纳入7项前瞻性研究(n=813),比较骨少肌症与单纯低骨密度或单纯肌少症在≥50岁人群中的跌倒和骨折风险。结果显示骨少肌症骨折风险与低骨密度相似但高于肌少症,跌倒风险无差异,无显著协同交互作用。

要点

  • 骨少肌症骨折风险与低骨密度相似(RR 1.22),但高于肌少症(RR 2.12)。
  • 骨少肌症跌倒风险与低骨密度或肌少症均无显著差异。
  • 无显著相加或相乘交互作用,证据不足以支持骨少肌症作为独立诊断实体。

核心结论

  • 骨少肌症发生骨折的风险与低骨密度相似,但高于肌少症;跌倒风险在骨少肌症与低骨密度或肌少症之间无差异。
  • 无显著相加或相乘交互作用,证据不足以支持将骨少肌症作为独立诊断实体推广。

研究设计与样本

  • 系统综述与荟萃分析,检索数据库从建库至2025年的前瞻性研究。
  • 纳入比较≥50岁人群中骨少肌症与单纯低骨密度(T值<-1.0)或单纯肌少症的跌倒和骨折风险的研究。
  • 共纳入7条记录(n=813)。

主要发现

  • 骨少肌症与低骨密度相比骨折风险相似(RR 1.22;95%CI 0.96,1.56;k=6,I2=0%)。
  • 骨少肌症与肌少症相比骨折风险更高(RR 2.12;95%CI 1.42,3.15;k=5;I2=0%)。
  • 骨少肌症与低骨密度相比跌倒风险无差异(RR 1.15;95%CI 0.44,2.97;k=3,I2=72.9%)。
  • 骨少肌症与肌少症相比跌倒风险无差异(RR 1.06;95%CI 0.70,1.59;k=3;I2=1.1%)。

关键数值与推荐

  • 骨折的相加交互作用RERI为0.35(95%CI -0.22,0.91;k=5),相乘交互作用MR为1.21(95%CI 0.90,1.62)。
  • 跌倒的相加交互作用RERI为-0.16(95%CI -0.60,0.28;k=3),相乘交互作用MR为0.83(95%CI 0.64,1.09)。

临床怎么用

  • 临床评估≥50岁人群时,骨少肌症患者的骨折风险应视为与低骨密度相似,但高于单纯肌少症。
  • 跌倒风险评估在骨少肌症、低骨密度和肌少症之间无显著差异,应同等重视。
  • 目前证据不支持将骨少肌症作为独立诊断实体进行特殊干预。

局限性

  • 纳入研究数量少(7条记录,n=813),部分分析异质性较高(如跌倒与低骨密度比较I2=72.9%)。
  • 仅纳入前瞻性研究,可能存在发表偏倚和其他混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

It is unclear whether comorbid low bone mineral density (BMD) and sarcopenia, known as 'osteosarcopenia', synergistically increase fall and fracture risk. This review aims to determine whether osteosarcopenia confers a greater risk for incident falls and fractures than low BMD or sarcopenia alone. Relevant databases were searched from inception to 2025 for prospective studies in populations aged ≥ 50 years comparing fall and fracture risk in osteosarcopenia to low BMD (T-Score < -1.0) or sarcopenia alone. Meta-analyses calculated risk ratios (RR) and measures of interaction on additive (relative excess risk due to interaction; RERI) and multiplicative (multiplicative interaction ratio; MR) scales. Seven records (n = 813) were included. Osteosarcopenia was associated with similar fracture risk as low BMD (RR 1.22; 95% CI 0.96, 1.56; k = 6, I2 = 0%), but higher risk than sarcopenia (RR 2.12; 95% CI 1.42, 3.15; k = 5; I2 = 0%). Falls risk did not differ for osteosarcopenia compared to low BMD (RR 1.15; 95% CI 0.44, 2.97; k = 3; I2 = 72.9%) or sarcopenia (RR 1.06; 95% CI 0.70, 1.59; k = 3; I2 = 1.1%). Synergy analyses showed pooled RERI of 0.35 (95% CI - 0.22, 0.91; k = 5) for fractures and - 0.16 (95% CI - 0.60, 0.28; k = 3) for falls, with MR estimates of 1.21 (95% CI 0.90 to 1.62) and 0.83 (95% CI, 0.64 to 1.09), respectively. Risk of incident fracture in osteosarcopenia is similar to that of low BMD, but higher than sarcopenia, and falls risk does not differ between conditions. The absence of significant additive or multiplicative interactions suggests there is insufficient evidence to support the promotion of osteosarcopenia as a distinct diagnostic entity.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Glavas C, Ryan JR, Breasail MÓ, et al. Does osteosarcopenia synergistically increase risk for incident falls and fractures? A systematic review and meta-analysis. Osteoporos Int. 2026. PMID: 41870606. doi:10.1007/s00198-026-07967-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。